PrimeCog: Primary Care Cognitive Testing
NCT06346535, Recruiting, Region Östergötland
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | PrimeCog: Primary Care Cognitive Testing | ClinicalTrials.gov |
| NCT number | NCT06346535 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Enrollment | 300 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Region Östergötland | ClinicalTrials.gov |
| Conditions | Mental Health Issue, Cognitive Symptom, Primary Health Care | ClinicalTrials.gov |
| Interventions | Cognitive Testing | ClinicalTrials.gov |
| First posted | 2024-04-04 | ClinicalTrials.gov |
| Last updated | 2024-04-23 | ClinicalTrials.gov |
Registered outcomes 16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Cognitive Test Results regarding attention and processing speed | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding attention and processing speed measured by TMT-A vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding attention and processing speed | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding attention and processing speed measured by TMT-B vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding attention and processing speed | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding attention and processing speed measured by SDPTvary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding attention and processing speed | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding attention and processing speed measured by Reaction Time Test Simple vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding memory | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding memory, measured by Corsi Span forward and backward, vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding memory | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding memory, measured by RAVLT Learning and Recall vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding executive function | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding executive functions, measured by TMT-B, vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding executive function | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding executive functions, measured by Reaction Time Test Complex (or CPT) vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding executive function | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding executive functions, measured by Stroop Test vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding language | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding language, measured by FAS vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding language | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding language, measured by Boston Naming Test vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Primary | Cognitive Test Results regarding visuospatial capacity | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do cognitive test results regarding visuospatial capacity measured by: Cube Copying Test, vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Secondary | MRI features, measured by morphological and quantitative MR sequences of the brain | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How do morphological as well as quantitative MR sequences, with and without intravenous contrast agent with following vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Secondary | Biochemical Profile in blood regarding inflammation, stress and neurodegeneration | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How the biochemical profile in blood vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Secondary | Biochemical Profile in saliva regarding inflammation and stress | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How the biochemical profile in saliva as described above vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
| Secondary | Biochemical Profile in hair regarding exposure to stress | At baseline, i.e. at diagnosis, at first study-specific follow-up (12 months from baseline), and at second study-specific follow-up (24 months from baseline) | How the biochemical profile in hair as described above vary between individuals with MDD/SED and HC? | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Corsi Block-Tapping Test | Primary outcome | ConductCognition |
| Picture Naming Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.3.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
Release trials-2026-11-12-0.3.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.